IPP Bureau
Stryker launches Trident II Hip System in India
By IPP Bureau - April 28, 2026
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
From losses to lift-off: Astec gains ground in Q4 FY26
By IPP Bureau - April 28, 2026
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
Jagsonpal Pharma profit surges 31% in Q4
By IPP Bureau - April 28, 2026
Rs. 40 cr buyback, 200% dividend announced
BPL Medical launches Blood Glucose Meter 582 for faster, easier diabetes monitoring
By IPP Bureau - April 28, 2026
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
Piramal Pharma Solutions appoints Gregory Judge as Director to strengthen European business
By IPP Bureau - April 28, 2026
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
AKUMS launches Aztreonam-Avibactam injection to combat multidrug-resistant infections
By IPP Bureau - April 28, 2026
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
HyugaLife raises Rs 100 crore in Series A to boost AI personalisation and offline expansion
By IPP Bureau - April 28, 2026
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
By IPP Bureau - April 28, 2026
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Aurigene bets big on CRDMO expansion with $100 million outlay
By IPP Bureau - April 28, 2026
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Ahmedabad hosts national conclave on urban pest and vector control strategies
By IPP Bureau - April 28, 2026
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease
By IPP Bureau - April 28, 2026
The submission is backed by positive results from the Phase 3 AFFIRM study
Essilor Stellest lens positioned as key breakthrough in myopia control in India
By IPP Bureau - April 28, 2026
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care
By IPP Bureau - April 28, 2026
The approval was driven by data from the Phase III TULIP-SC trial
LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India
By IPP Bureau - April 27, 2026
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
By IPP Bureau - April 27, 2026
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
